GO TEAM!!! This is a compiled report on Virta’s 70 day and 1 year study manuscripts via Inkinen’s Twitter page today:
"We’ve also analyzed the cost savings among our clinical trial patients and estimate that the Virta Treatment delivers employer savings of nearly $10,000 in the first 24 months for each person living with type 2 diabetes.* What this means is that the Virta Treatment not only saves lives, but also saves tax payers, employers, health plans and individuals a lot of money in the process.
The skeptics will still ask: but you must have cherry picked your patients—can this scale across other populations? So far, the answer is yes. The Virta Treatment is now available in all 50 states, and we’ve treated thousands of patients across states, health plans and employers."